Enanta Pharmaceuticals, Inc. (ENTA)
11.52
-0.78
(-6.34%)
USD |
NASDAQ |
Oct 13, 16:00
11.54
+0.02
(+0.17%)
After-Hours: 20:00
Enanta Pharmaceuticals EPS Diluted (TTM) : -2.411 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.411 |
| March 31, 2026 | -2.595 |
| December 31, 2025 | -3.204 |
| September 30, 2025 | -3.838 |
| June 30, 2025 | -4.324 |
| March 31, 2025 | -4.540 |
| December 31, 2024 | -4.952 |
| September 30, 2024 | -5.486 |
| June 30, 2024 | -5.461 |
| March 31, 2024 | -6.246 |
| December 31, 2023 | -6.565 |
| September 30, 2023 | -6.373 |
| June 30, 2023 | -6.308 |
| March 31, 2023 | -5.983 |
| December 31, 2022 | -5.827 |
| September 30, 2022 | -5.912 |
| June 30, 2022 | -5.859 |
| March 31, 2022 | -5.517 |
| December 31, 2021 | -4.976 |
| September 30, 2021 | -3.913 |
| June 30, 2021 | -4.158 |
| March 31, 2021 | -3.682 |
| December 31, 2020 | -2.89 |
| September 30, 2020 | -1.828 |
| June 30, 2020 | 0.0735 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.119 |
| December 31, 2019 | 1.617 |
| September 30, 2019 | 2.220 |
| June 30, 2019 | 3.082 |
| March 31, 2019 | 3.718 |
| December 31, 2018 | 4.132 |
| September 30, 2018 | 3.472 |
| June 30, 2018 | 4.03 |
| March 31, 2018 | 2.62 |
| December 31, 2017 | 1.73 |
| September 30, 2017 | 0.88 |
| June 30, 2017 | -1.075 |
| March 31, 2017 | -0.6947 |
| December 31, 2016 | -0.5047 |
| September 30, 2016 | 1.115 |
| June 30, 2016 | 1.50 |
| March 31, 2016 | 1.69 |
| December 31, 2015 | 3.27 |
| September 30, 2015 | 4.09 |
| June 30, 2015 | 3.53 |
| March 31, 2015 | 6.01 |
| December 31, 2014 | 4.24 |
| September 30, 2014 | 1.76 |
| June 30, 2014 | 1.78 |
| March 31, 2014 | -1.06 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Perspective Therapeutics, Inc. | -1.329 |
| Coherus Oncology, Inc. | -1.021 |
| BridgeBio Pharma, Inc. | -3.569 |
| RenovoRx, Inc. | -0.314 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |